Read about NIAID’s study suggesting that VSV is a viable delivery system, or vector, for sequential vaccines against Lassa and Ebola viruses.
There are no specific drugs to treat Ebola or Marburg hemorrhagic fevers. If hospitalized, ill people can be given supportive care such as intravenous fluids.
Last Updated May 14, 2010
Last Reviewed May 14, 2010